Quantitative comparison of the protein corona of nanoparticles with different matrices.
Cholesterol
Lipidic nanoparticles
Nanomedicine
Polymeric PLGA nanoparticles
Protein corona
Targeted nanomedicines
Journal
International journal of pharmaceutics: X
ISSN: 2590-1567
Titre abrégé: Int J Pharm X
Pays: Netherlands
ID NLM: 101753452
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
07
08
2022
revised:
18
10
2022
accepted:
19
10
2022
entrez:
28
10
2022
pubmed:
29
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
Nanoparticles (NPs) are paving the way for improved treatments for difficult to treat diseases diseases; however, much is unknown about their fate in the body. One important factor is the interaction between NPs and blood proteins leading to the formation known as the "protein corona" (PC). The PC, consisting of the Hard (HC) and Soft Corona (SC), varies greatly based on the NP composition, size, and surface properties. This highlights the need for specific studies to differentiate the PC formation for each individual NP system. This work focused on comparing the HC and SC of three NPs with different matrix compositions: a) polymeric NPs based on poly(lactic-
Identifiants
pubmed: 36304137
doi: 10.1016/j.ijpx.2022.100136
pii: S2590-1567(22)00025-1
pmc: PMC9594119
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100136Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
ACS Appl Mater Interfaces. 2016 Sep 7;8(35):22914-22
pubmed: 27560314
Small. 2017 Apr;13(16):
pubmed: 28196309
J Control Release. 2005 Nov 2;108(1):84-96
pubmed: 16154222
Mol Pharm. 2018 Nov 5;15(11):5019-5030
pubmed: 30222356
Acc Chem Res. 2019 Jun 18;52(6):1632-1642
pubmed: 31181913
Semin Immunol. 2017 Dec;34:52-60
pubmed: 29066063
Int J Mol Sci. 2019 Apr 24;20(8):
pubmed: 31022913
Nat Rev Immunol. 2010 Nov;10(11):778-86
pubmed: 20948548
Nat Nanotechnol. 2013 Feb;8(2):137-43
pubmed: 23334168
Immunol Cell Biol. 2020 Apr;98(4):305-317
pubmed: 32142167
Pharmaceutics. 2021 Sep 17;13(9):
pubmed: 34575571
Nat Nanotechnol. 2013 Oct;8(10):772-81
pubmed: 24056901
Sci Rep. 2020 Jun 15;10(1):9664
pubmed: 32541900
J Pharmacol Exp Ther. 2006 Jun;317(3):1246-53
pubmed: 16554356
ACS Nano. 2013 Dec 23;7(12):10960-70
pubmed: 24256422
Molecules. 2020 Oct 09;25(20):
pubmed: 33050145
Nanomaterials (Basel). 2021 Mar 31;11(4):
pubmed: 33807228
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14265-70
pubmed: 18809927
Int J Biol Macromol. 2021 Feb 1;169:290-301
pubmed: 33340622
Front Bioeng Biotechnol. 2020 Apr 03;8:166
pubmed: 32309278
ACS Appl Mater Interfaces. 2018 Mar 14;10(10):9094-9103
pubmed: 29473734
Sci Rep. 2017 Sep 5;7(1):10542
pubmed: 28874846
ACS Nano. 2013 Aug 27;7(8):6555-62
pubmed: 23808533
J Pers Med. 2017 Oct 12;7(4):
pubmed: 29023366
Adv Colloid Interface Sci. 2021 Mar;289:102366
pubmed: 33540289
PLoS One. 2012;7(3):e32568
pubmed: 22396775
J Am Chem Soc. 2012 Mar 7;134(9):3965-7
pubmed: 22339432
Nanoscale. 2015 Sep 7;7(33):13958-66
pubmed: 26222625
Chem Soc Rev. 2012 Apr 7;41(7):2780-99
pubmed: 22086677
Biomed Pharmacother. 2021 Jul;139:111541
pubmed: 33848776
Arch Toxicol. 2017 Mar;91(3):1031-1048
pubmed: 27438349
ACS Nano. 2012 Mar 27;6(3):2532-41
pubmed: 22356488
Biomacromolecules. 2016 Mar 14;17(3):935-45
pubmed: 26871486
Int Rev Neurobiol. 2017;137:1-28
pubmed: 29132540
J Am Chem Soc. 2012 Mar 7;134(9):4100-3
pubmed: 22339401
Bioinformatics. 2014 Sep 1;30(17):2524-6
pubmed: 24794931
Front Immunol. 2016 Oct 10;7:418
pubmed: 27777575
Nanoscale. 2014 Mar 7;6(5):2782-92
pubmed: 24463404
Int J Pharm. 2015 Oct 15;494(1):430-44
pubmed: 26315125
Bioeng Transl Med. 2017 May 22;2(2):180-190
pubmed: 28932819
Science. 1988 Apr 29;240(4852):622-30
pubmed: 3283935
J Biol Chem. 2002 Mar 22;277(12):9645-54
pubmed: 11744719
J Control Release. 2021 Feb 10;330:587-598
pubmed: 33412229
Adv Drug Deliv Rev. 2011 Sep 16;63(12):1000-7
pubmed: 21689701
Nanomaterials (Basel). 2021 Nov 03;11(11):
pubmed: 34835710
Int J Nanomedicine. 2017 Apr 18;12:3137-3151
pubmed: 28458536
ACS Nano. 2015 Aug 25;9(8):8142-56
pubmed: 26135229
Cancers (Basel). 2019 May 08;11(5):
pubmed: 31072061
Nanoscale. 2018 Jan 18;10(3):1256-1264
pubmed: 29292433
Prog Biophys Mol Biol. 2003 Sep;83(1):47-68
pubmed: 12757750
Nanomedicine. 2014 Oct;10(7):1453-63
pubmed: 24512761
Front Bioeng Biotechnol. 2020 Mar 20;8:210
pubmed: 32266237
J Control Release. 2018 Feb 28;272:39-53
pubmed: 29305922
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Jul;10(4):e1500
pubmed: 29071798
Toxicol Sci. 2015 Jan;143(1):136-46
pubmed: 25326241
Eur J Pharm Biopharm. 2019 Aug;141:70-80
pubmed: 31082511
Biochim Biophys Acta Gen Subj. 2019 May;1863(5):971-991
pubmed: 30802594
J Am Chem Soc. 2022 Jun 1;144(21):9184-9205
pubmed: 35536591
Adv Exp Med Biol. 2018;1048:175-198
pubmed: 29453539
ACS Nano. 2015 Mar 24;9(3):2876-85
pubmed: 25712076
Int J Nanomedicine. 2020 Mar 06;15:1481-1498
pubmed: 32189964
Langmuir. 2009 Apr 21;25(8):4571-8
pubmed: 19366224
Int J Pharm. 2006 Jan 3;307(1):93-102
pubmed: 16303268
Cell Prolif. 2015 Aug;48(4):465-74
pubmed: 26017818
J Control Release. 2007 Sep 11;122(1):1-9
pubmed: 17651855
J Lipid Res. 1995 Feb;36(2):211-28
pubmed: 7751809
Mater Sci Eng C Mater Biol Appl. 2019 Dec;105:110080
pubmed: 31546390
ACS Nano. 2012 Jul 24;6(7):5845-57
pubmed: 22721453
Pharmaceutics. 2019 Nov 01;11(11):
pubmed: 31683907
Int J Nanomedicine. 2020 Aug 06;15:5783-5802
pubmed: 32821101
Langmuir. 2011 Jun 21;27(12):7722-31
pubmed: 21591651
Expert Opin Drug Deliv. 2021 Jul;18(7):991-1004
pubmed: 33703991
Acta Biomater. 2021 Jul 15;129:57-72
pubmed: 34048973
Int J Pharm. 2016 Sep 10;511(1):331-340
pubmed: 27418565
Protein Pept Lett. 2008;15(4):360-4
pubmed: 18473948
ACS Nano. 2011 Jun 28;5(6):4658-69
pubmed: 21545143
Nat Commun. 2020 Sep 10;11(1):4535
pubmed: 32913217
Nat Nanotechnol. 2012 Dec;7(12):779-86
pubmed: 23212421
Nano Lett. 2014 Jan 8;14(1):6-12
pubmed: 24328336
Biomaterials. 2014 Aug;35(24):6182-94
pubmed: 24831972
Pharmaceutics. 2020 Jan 17;12(1):
pubmed: 31963430
Biophys J. 2002 Mar;82(3):1453-9
pubmed: 11867460
ACS Nano. 2016 Apr 26;10(4):4421-30
pubmed: 27040442
Colloids Surf B Biointerfaces. 2014 Nov 1;123:143-9
pubmed: 25262409
Nanomedicine. 2020 Aug;28:102226
pubmed: 32479916
Nano Lett. 2007 Apr;7(4):914-20
pubmed: 17335269
J Am Chem Soc. 2011 Mar 2;133(8):2525-34
pubmed: 21288025
Biomedicines. 2021 Oct 19;9(10):
pubmed: 34680613
Eur J Pharm Biopharm. 2013 Sep;85(1):53-60
pubmed: 23395970
Materials (Basel). 2021 Mar 28;14(7):
pubmed: 33800633
Methods Mol Biol. 2014;1156:213-22
pubmed: 24791991
J Am Chem Soc. 2005 Jun 8;127(22):8168-73
pubmed: 15926845
Colloids Surf B Biointerfaces. 2013 Apr 1;104:213-20
pubmed: 23318220
Trends Biotechnol. 2017 Mar;35(3):257-264
pubmed: 27663778
Langmuir. 2011 Mar 15;27(6):2464-77
pubmed: 21341776
Langmuir. 2011 Dec 20;27(24):15048-53
pubmed: 22043822
Int J Nanomedicine. 2019 Jan 18;14:667-687
pubmed: 30705586
Int J Pharm. 2018 Dec 1;552(1-2):328-339
pubmed: 30308270
Nanoscale Adv. 2021 Jan 13;3(5):1209-1229
pubmed: 36132858
Nat Commun. 2017 Oct 3;8(1):777
pubmed: 28974673
ACS Nano. 2011 Sep 27;5(9):7155-67
pubmed: 21866933
Nanomedicine (Lond). 2018 Feb;13(4):407-422
pubmed: 29345202
J Control Release. 2012 Jul 20;161(2):403-8
pubmed: 22306428
Int J Pharm. 2000 Mar 10;196(2):245-9
pubmed: 10699728
Adv Drug Deliv Rev. 2021 Sep;176:113887
pubmed: 34314785
ACS Nano. 2019 Oct 22;13(10):11107-11121
pubmed: 31525954
ACS Nano. 2017 Dec 26;11(12):11773-11776
pubmed: 29206030
J Mater Chem B. 2021 Feb 15;9(5):1351-1363
pubmed: 33447840
Int J Biol Macromol. 2022 Jul 1;212:358-369
pubmed: 35618086
Small. 2020 Nov;16(46):e2000892
pubmed: 33107223
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8691-6
pubmed: 17485668
Nat Nanotechnol. 2017 May;12(4):387-393
pubmed: 27992410
J Drug Target. 2002 Jun;10(4):317-25
pubmed: 12164380
ACS Nano. 2010 Jan 26;4(1):365-79
pubmed: 20020753
Mater Sci Eng C Mater Biol Appl. 2020 Apr;109:110576
pubmed: 32228957
Nanomedicine (Lond). 2015 Jan;10(2):215-26
pubmed: 25600967
J Immunol Methods. 2019 Oct;473:112630
pubmed: 31301278
Front Bioeng Biotechnol. 2021 Mar 31;9:646708
pubmed: 33869157
Proteomics. 2011 Dec;11(23):4569-77
pubmed: 21956884
Nanomedicine. 2009 Jun;5(2):106-17
pubmed: 19071065
ACS Appl Mater Interfaces. 2014 Sep 10;6(17):15412-9
pubmed: 25144382
J Fluoresc. 2010 Jan;20(1):371-6
pubmed: 19644737
Angew Chem Int Ed Engl. 2007;46(30):5754-6
pubmed: 17591736
Colloids Surf B Biointerfaces. 2019 Jul 1;179:505-516
pubmed: 31009853
J Multidiscip Healthc. 2021 Jul 05;14:1711-1724
pubmed: 34267523
Int J Pharm. 2018 May 30;543(1-2):300-310
pubmed: 29608954
Eur J Pharm Sci. 2022 Jul 1;174:106199
pubmed: 35533965
Beilstein J Nanotechnol. 2019 May 6;10:1002-1015
pubmed: 31165027
Langmuir. 2013 May 28;29(21):6485-94
pubmed: 23631648
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2050-5
pubmed: 17267609